Prepartum bumetanide treatment reverses altered neonatal social communication but nonspecifically reduces postpubertal social behavior in a mouse model of fragile X syndrome
Open Access
- 24 December 2024
- journal article
- Published by Genomic Press in Genomic Psychiatry
- Vol. 1 (1) , 61-72
Abstract
Fragile X syndrome is caused by monogenic silencing of the FMR1 gene and is characterized by high rates of autism spectrum disorder. A previous study demonstrated that prepartum administration of bumetanide, a chloride transporter blocker, normalized neonatal vocalization in non-congenic Fmr1 knockout (KO) pups. However, the genuine contribution of Fmr1 deletion to this phenotype in a congenic Fmr1 KO mouse model and the long-lasting effect of prepartum bumetanide administration on postpubertal social interaction remains unclear. The current study aimed to determine the impact of prepartum bumetanide administration on vocalization at postnatal day 7 and social interaction at 6 and 8 weeks of age in a congenic Fmr1 KO mouse model in which the genetic backgrounds were homogeneous between KO and wild-type (WT) littermates. Moreover, we applied a computational analytical algorithm and determined predictive variables of neonatal vocalization for postpubertal social interaction. Our data showed that (1) KO mice exhibited altered numbers and sequences of distinct call types during neonatal vocalization and reduced social interaction at 6 weeks, (2) select sets of neonatal vocalization variables predicted postpubertal social interaction levels, and (3) bumetanide restored neonatal vocalization in KO pups but nonspecifically reduced social interaction in WT and KO mice at 6 weeks. These data indicate that Fmr1 deletion selectively impacts distinct elements of neonatal vocalization and postpubertal social interaction. Additionally, bumetanide selectively restores neonatal vocalization but has a transient nonspecific negative impact on subsequent postpubertal social interaction.Keywords
This publication has 46 references indexed in Scilit:
- The NKCC1 Inhibitor Bumetanide Restores Cortical Feedforward Inhibition and Lessens Sensory Hypersensitivity in Early Postnatal Fragile X MiceBiological Psychiatry, 2024
- Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studiesAutism Research, 2023
- Maternal approach behaviors toward neonatal calls are impaired by mother's experiences of raising pups with a risk gene variant for autismDevelopmental Psychobiology, 2020
- Computational Analysis of Neonatal Mouse Ultrasonic VocalizationCurrent Protocols in Mouse Biology, 2018
- Deletion of Fmr1 results in sex‐specific changes in behaviorBrain and Behavior, 2017
- Temporal and spectral differences in the ultrasonic vocalizations of fragile X knock out mice during postnatal developmentBehavioural Brain Research, 2014
- Assessing autism-like behavior in mice: Variations in social interactions among inbred strainsBehavioural Brain Research, 2007
- Social Approach and Autistic Behavior in Children with Fragile X SyndromeJournal of Autism and Developmental Disorders, 2006
- A Mouse Model System for Genetic Analysis of Sociability: C57BL/6J Versus BALB/cJ Inbred Mouse StrainsBiological Psychiatry, 2006
- Social behavior deficits in the Fmr1 mutant mouseBehavioural Brain Research, 2006